118 related articles for article (PubMed ID: 30809306)
21. A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase.
Besse HC; Chen Y; Scheeren HW; Metselaar JM; Lammers T; Moonen CTW; Hennink WE; Deckers R
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32532061
[TBL] [Abstract][Full Text] [Related]
22. Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic approach with doxorubicin.
Martins-Marques T; Pinho MJ; Zuzarte M; Oliveira C; Pereira P; Sluijter JP; Gomes C; Girao H
J Extracell Vesicles; 2016; 5():32538. PubMed ID: 27702427
[TBL] [Abstract][Full Text] [Related]
23. Cellular Trafficking of Sn-2 Phosphatidylcholine Prodrugs Studied with Fluorescence Lifetime Imaging and Super-resolution Microscopy.
Maji D; Lu J; Sarder P; Schmieder AH; Cui G; Yang X; Pan D; Lew MD; Achilefu S; Lanza GM
Precis Nanomed; 2018 Jul; 1(2):128-145. PubMed ID: 31249994
[TBL] [Abstract][Full Text] [Related]
24. Coordinating bioorthogonal reactions with two tumor-microenvironment-responsive nanovehicles for spatiotemporally controlled prodrug activation.
Zuo L; Ding J; Li C; Lin F; Chen PR; Wang P; Lu G; Zhang J; Huang LL; Xie HY
Chem Sci; 2020 Jan; 11(8):2155-2160. PubMed ID: 34123305
[TBL] [Abstract][Full Text] [Related]
25. A Tumor-Specific Cascade-Activating Smart Prodrug System for Enhanced Targeted Therapy.
Wang Q; Jin D; Liu C; Shi L; Li T
Small; 2024 Jun; 20(24):e2309482. PubMed ID: 38150668
[TBL] [Abstract][Full Text] [Related]
26. Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy.
Cho H; Shim MK; Yang S; Song S; Moon Y; Kim J; Byun Y; Ahn CH; Kim K
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056979
[TBL] [Abstract][Full Text] [Related]
27. Stimuli-responsive biotin-anchored prodrug for the targeted delivery of anti-cancer agent NBDHEX with turn-on NIR fluorescence.
Kesarwani R; Pal N; Bhabak KP
Chem Commun (Camb); 2024 Mar; 60(25):3397-3400. PubMed ID: 38404238
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced prodrug activation: extending combined modality therapy for some solid tumours.
Farrer NJ; Higgins GS; Kunkler IH
Br J Cancer; 2022 May; 126(9):1241-1243. PubMed ID: 35217798
[TBL] [Abstract][Full Text] [Related]
29. The use of thermographic imaging to evaluate therapeutic response in human tumour xenograft models.
Hussain N; Connah D; Ugail H; Cooper PA; Falconer RA; Patterson LH; Shnyder SD
Sci Rep; 2016 Aug; 6():31136. PubMed ID: 27491535
[TBL] [Abstract][Full Text] [Related]
30. Combinatorial Therapy: Targeting CD133+ Glioma Stem-like Cells with a Polysaccharide-Prodrug Complex Functionalised Gold Nanocages.
Raveendran S; Giram A; Elmi M; Ray S; Ireson C; Alavijeh M; Savina IN
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790896
[TBL] [Abstract][Full Text] [Related]
31. Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy.
Gao H; Wu Y; Shi J; Zhang X; Liu T; Hu B; Jia B; Wan Y; Liu Z; Wang F
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203663
[TBL] [Abstract][Full Text] [Related]
32. First-in-human pilot study of an integrin α6-targeted radiotracer for SPECT imaging of breast cancer.
Gao S; Jia B; Feng G; Dong C; Du H; Bai L; Zhong Q; Ma Q; Zeng M; Wang F
Signal Transduct Target Ther; 2020 Aug; 5(1):147. PubMed ID: 32782265
[No Abstract] [Full Text] [Related]
33. Host-Guest Polypyrrole Nanocomplex for Three-Stimuli-Responsive Drug Delivery and Imaging-Guided Chemo-Photothermal Synergetic Therapy of Refractory Thyroid Cancer.
Ma X; Li X; Shi J; Yao M; Zhang X; Hou R; Shao N; Luo Q; Gao Y; Du S; Liang X; Wang F
Adv Healthc Mater; 2019 Sep; 8(17):e1900661. PubMed ID: 31389191
[TBL] [Abstract][Full Text] [Related]
34. In situ conversion of rose bengal microbubbles into nanoparticles for ultrasound imaging guided sonodynamic therapy with enhanced antitumor efficacy.
Hou R; Liang X; Li X; Zhang X; Ma X; Wang F
Biomater Sci; 2020 May; 8(9):2526-2536. PubMed ID: 32215400
[TBL] [Abstract][Full Text] [Related]
35. Imaging and monitoring HER2 expression in breast cancer during trastuzumab therapy with a peptide probe
Wu Y; Li L; Wang Z; Shi J; Hu Z; Gao S; Miao W; Ma Q; Dong C; Wang F
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2613-2623. PubMed ID: 32170344
[TBL] [Abstract][Full Text] [Related]
36. Highly stable near-infrared dye conjugated cerasomes for fluorescence imaging-guided synergistic chemo-photothermal therapy of colorectal cancer.
Zhang X; Liang X; Ma X; Hou R; Li X; Wang F
Biomater Sci; 2019 Jul; 7(7):2873-2888. PubMed ID: 31070203
[TBL] [Abstract][Full Text] [Related]
37. High Intensity Focused Ultrasound-Responsive and Ultrastable Cerasomal Perfluorocarbon Nanodroplets for Alleviating Tumor Multidrug Resistance and Epithelial-Mesenchymal Transition.
Ma X; Yao M; Shi J; Li X; Gao Y; Luo Q; Hou R; Liang X; Wang F
ACS Nano; 2020 Nov; 14(11):15904-15918. PubMed ID: 33175487
[TBL] [Abstract][Full Text] [Related]
38. A micelle-based stage-by-stage impelled system for efficient doxorubicin delivery.
Li S; Li F; Wan D; Chen Z; Pan J; Liang XJ
Bioact Mater; 2023 Jul; 25():783-795. PubMed ID: 37056277
[TBL] [Abstract][Full Text] [Related]
39. Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis.
Subhan MA; Parveen F; Filipczak N; Yalamarty SSK; Torchilin VP
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983571
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy.
Askarizadeh A; Mashreghi M; Mirhadi E; Mirzavi F; Shargh VH; Badiee A; Alavizadeh SH; Arabi L; Jaafari MR
Cancer Nanotechnol; 2023; 14(1):18. PubMed ID: 36910721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
